Biocraft School Of Pre-Clinicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 28.98%
(FY 2023)
- Ebitda 28.98%
(FY 2023)
- Net Worth -20.82%
(FY 2023)
- Total Assets -0.79%
(FY 2023)
About Biocraft School Of Pre-Clinicals
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shankarappa Babu and Kothapalli Raghunatha serve as directors at the Company.
- CIN/LLPIN
U80904KA2012PTC064034
- Company No.
064034
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 May 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Biocraft School Of Pre-Clinicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kothapalli Raghunatha  | Director | 16-May-2012 | Current |
| Shankarappa Babu | Director | 16-May-2012 | Current |
Financial Performance and Corporate Structure Insights of Biocraft School Of Pre-Clinicals.
Biocraft School Of Pre-Clinicals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 28.98% increase in profit. The company's net worth observed a substantial decline by a decrease of 20.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biocraft School Of Pre-Clinicals?
Unlock access to Biocraft School Of Pre-Clinicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Peenya Food & Drug Testing Lab Private LimitedActive 7 years 5 months
Shankarappa Babu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biocraft School Of Pre-Clinicals?
Unlock and access historical data on people associated with Biocraft School Of Pre-Clinicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biocraft School Of Pre-Clinicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocraft School Of Pre-Clinicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
